AXL+SIGLEC6+ dendritic cells in cerebrospinal fluid and brain tissues of patients with autoimmune inflammatory demyelinating disease of CNS
Clinical Immunology · 2023
DOI: 10.1016/j.clim.2023.109686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2023. Verfasst von Junho Kang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
Inflammatory demyelinating disease of the CNS (IDD) is a heterogeneous group of autoimmune diseases, and multiple sclerosis is the most common type. Dendritic cells (DCs), major antigen-presenting cells, have been proposed to play a central role in the pathogenesis of IDD. The AXL+SIGLEC6+ DC (ASDC) has been only recently identified in humans and has a high capability of T cell activation. Nevertheless, its contribution to CNS autoimmunity remains still obscure. Here, we aimed to identify the ASDC in diverse sample types from IDD patients and experimental autoimmune encephalomyelitis (EAE). A detailed analysis of DC subpopulations using single-cell transcriptomics for the paired cerebrospinal fluid (CSF) and blood samples of IDD patients (total n = 9) revealed that three subtypes of DCs (ASDCs, ACY3+ DCs, and LAMP3+ DCs) were overrepresented in CSF compared with their paired blood. Among these DCs, ASDCs were also more abundant in CSF of IDD patients than in controls, manifesting poly-adhesional and stimulatory characteristics. In the brain biopsied tissues of IDD patients, obtained at the acute attack of disease, ASDC were also frequently found in close contact with T cells. Lastly, the frequency of ASDC was found to be temporally more abundant in acute attack of disease both in CSF samples of IDD patients and in tissues of EAE, an animal model for CNS autoimmunity. Our analysis suggests that the ASDC might be involved in the pathogenesis of CNS autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
- Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Neurology, Seoul National University Hospital, Seoul National University of Medicine, Seoul, Republic of Korea.
- Department of Pathology, Seoul National University Hospital, Seoul National University of Medicine, Seoul, Republic of Korea.
- Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. Electronic address: jp24@kaist.ac.kr.
Zitieren
APA
Kang, J., Kim, M., Yoon, D. Y., Kim, W. S., Choi, S. J., Kwon, Y. N., Kim, W. S., Park, S. H., Sung, J. J., Park, M., Lee, J. S., Park, J. E., & Kim, S. M. (2023). AXL+SIGLEC6+ dendritic cells in cerebrospinal fluid and brain tissues of patients with autoimmune inflammatory demyelinating disease of CNS. Clinical Immunology. https://doi.org/10.1016/j.clim.2023.109686
Vancouver
Kang J, Kim M, Yoon DY, Kim WS, Choi SJ, Kwon YN, et al. AXL+SIGLEC6+ dendritic cells in cerebrospinal fluid and brain tissues of patients with autoimmune inflammatory demyelinating disease of CNS. Clinical Immunology. 2023. doi:10.1016/j.clim.2023.109686
BibTeX
@article{Kang2023,
author = {Kang, Junho and Kim, Moonhang and Yoon, Da-Young and Kim, Woo-Seok and Choi, Seok-Jin and Kwon, Young-Nam and Kim, Won-Seok and Park, Sung-Hye and Sung, Jung-Joon and Park, Myungsun and Lee, Jung Seok and Park, Jong-Eun and Kim, Sung-Min},
title = {AXL+SIGLEC6+ dendritic cells in cerebrospinal fluid and brain tissues of patients with autoimmune inflammatory demyelinating disease of CNS},
journal = {Clinical Immunology},
year = {2023},
doi = {10.1016/j.clim.2023.109686}
}
EUVIMED